IBD & Intestinal Disorders
Conference Coverage
Ileocecal resection possible first-line option in early Crohn’s disease
Patients with early ileocecal Crohn’s disease who undergo ileocecal surgery remain off drug treatment 5 years later.
Conference Coverage
Pediatric IBD patients wrestle with lingering gut pain
Chronic pain in children and adolescents with IBD is not linked to disease activity, nonetheless it impacts emotional wellbeing which suggests...
Conference Coverage
IBD: More patients on vedolizumab vs. anti-TNFs at 2 years
Vedolizumab showed a higher overall 1- and 2-year persistence of use, compared with two anti–tumor necrosis factor inhibitors in both Crohn’s...
Conference Coverage
Cannabis tied to lower IBD mortality, hospital costs
Patients with inflammatory bowel disease who concurrently use cannabis show a highly significant reduction in inpatient mortality and hospital...
Short Clinical Reviews
Integrating intestinal ultrasound into inflammatory bowel disease training and practice in the United States
There is a great need to teach the next generation of gastroenterologists about IUS’ value, how to incorporate it into clinical practice, and how...
From the Journals
Does CRC risk in IBD extend to close family members?
Extra screening for CRC may not be needed for children, siblings, or parents of those with IBD, new study findings suggest.
From the Journals
AGA guideline defines role of biomarkers in ulcerative colitis
In many cases, biomarkers should be considered before pursuing endoscopy or treatment adjustments.
Feature
New influx of Humira biosimilars may not drive immediate change
As many as 8-10 adalimumab biosimilars are anticipated to come on the market this year, giving mainstay drug Humira some vigorous competition.
From the AGA Journals
Gastroparesis referrals often based on misdiagnosis
“Improperly performed GES appears to play a critical role in misdiagnosis” of gastroparesis.
Conference Coverage
Consider cultural differences in IBD diet planning
Clinicians should incorporate culturally sensitive discussions and recommendations into interactions with patients with inflammatory bowel disease...